newsfilter
← Latest News
GlobeNewswire·

CytoDyn to Present at the H.C. Wainwright 27th Annual Global Investment Conference

VANCOUVER, Washington, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB:CYDY) ("CytoDyn" or the "Company"), a clinical-stage biotechnology company advancing leronlimab, a first-in-class humanized